Home » Watson False Marking Suit Is Latest in a Worrying Trend for Drugmakers
Watson False Marking Suit Is Latest in a Worrying Trend for Drugmakers
August 31, 2010
For brand and generic pharmaceutical companies alike, defending patent litigation is an expected and often necessary part of doing business. But a new cottage industry of suing drugmakers for labeling their products with expired patents has emerged seemingly overnight and has the potential to inflict significant financial damage.